丸美生物
(603983)
| 流通市值：135.58亿 | | | 总市值：135.58亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,663,082,248.33 | 881,288,902.19 | 3,459,318,084 | 2,450,380,539.41 |
| 营业总成本 | 1,541,827,838.79 | 761,891,108.23 | 3,214,916,856.76 | 2,206,220,208.73 |
| 其他经营收益 | | | | |
| 营业利润 | 183,297,342.15 | 122,876,460.7 | 296,611,057.33 | 299,077,057.09 |
| 利润总额 | 182,837,793.18 | 123,226,746.62 | 295,731,444.58 | 298,521,477.37 |
| 净利润 | 156,955,422.13 | 100,997,752.2 | 246,742,825.83 | 246,649,316.64 |
| 每股收益 | | | | |
| 其他综合收益 | -265,302.03 | -24,389.15 | -22,246.12 | -73,087.1 |
| 综合收益总额 | 156,690,120.1 | 100,973,363.05 | 246,720,579.71 | 246,576,229.54 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,273,642,119.56 | 2,313,458,719.72 | 2,235,887,239.43 | 2,594,081,776.34 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,359,484,363.51 | 2,376,841,684.44 | 2,377,567,587.6 | 2,252,541,082.77 |
| 资产总计 | 4,633,126,483.07 | 4,690,300,404.16 | 4,613,454,827.03 | 4,846,622,859.11 |
| 流动负债: | | | | |
| 流动负债合计 | 1,170,252,760.28 | 1,177,205,446.12 | 1,198,807,998.54 | 1,436,832,268.97 |
| 非流动负债: | | | | |
| 非流动负债合计 | 25,223,703.62 | 20,518,103.88 | 20,471,583.62 | 18,504,584.46 |
| 负债合计 | 1,195,476,463.9 | 1,197,723,550 | 1,219,279,582.16 | 1,455,336,853.43 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,381,829,272.78 | 3,432,153,477.11 | 3,331,157,901.88 | 3,323,476,059.97 |
| 股东权益合计 | 3,437,650,019.17 | 3,492,576,854.16 | 3,394,175,244.87 | 3,391,286,005.68 |
| 负债和股东权益合计 | 4,633,126,483.07 | 4,690,300,404.16 | 4,613,454,827.03 | 4,846,622,859.11 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,756,014,205.95 | 930,399,940.57 | 3,998,479,620.31 | 2,558,200,460.24 |
| 经营活动现金流出小计 | 1,676,923,499.94 | 893,206,433.89 | 3,724,603,217.99 | 2,399,327,220.71 |
| 经营活动产生的现金流量净额 | 79,090,706.01 | 37,193,506.68 | 273,876,402.32 | 158,873,239.53 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 239,037,875.91 | 58,383,110.73 | 193,442,309.22 | 157,352,229.43 |
| 投资活动现金流出小计 | 129,342,129.59 | 102,559,880.66 | 507,377,767.2 | 324,299,465.9 |
| 投资活动产生的现金流量净额 | 109,695,746.32 | -44,176,769.93 | -313,935,457.98 | -166,947,236.47 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 405,494,253.05 | 122,193,293.33 | 1,437,822,791.35 | 440,309,091.9 |
| 筹资活动现金流出小计 | 398,211,945.57 | 135,979,845.26 | 2,035,556,308.49 | 823,106,804.3 |
| 筹资活动产生的现金流量净额 | 7,282,307.48 | -13,786,551.93 | -597,733,517.14 | -382,797,712.4 |
| 汇率变动对现金及现金等价物的影响 | -42,086.02 | -17,794.29 | -6,647.49 | 25,235.78 |
| 现金及现金等价物净增加额 | 196,026,673.79 | -20,787,609.47 | -637,799,220.29 | -390,846,473.56 |
| 期末现金及现金等价物余额 | 1,137,287,463.44 | 920,473,180.18 | 941,260,789.65 | 1,188,213,536.38 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 196,026,673.79 | - | -637,799,220.29 | - |
最新报告期：2026-09-07| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中金公司 | 徐卓楠,袁华远,黄蔓琪 | 0.76 | 0.90 | -- | 2026-09-07 |
| 万联证券 | 李滢 | 0.71 | 0.84 | 1.00 | 2026-09-07 |
| 国信证券 | 柳旭,张峻豪,孙乔容若 | 0.67 | 0.72 | 0.77 | 2026-09-03 |
| 华泰证券 | 孙丹阳,樊俊豪 | 0.76 | 0.96 | 1.18 | 2026-09-02 |
| 中泰证券 | 郑澄怀 | 0.83 | 1.01 | 1.19 | 2026-08-31 |